BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26147980)

  • 1. Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay.
    Cozma C; Eichler S; Wittmann G; Flores Bonet A; Kramp GJ; Giese AK; Rolfs A
    PLoS One; 2015; 10(7):e0131228. PubMed ID: 26147980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
    Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
    Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-Plex immunoassay measuring the quantity of lysosomal
    Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
    BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots.
    Ullal AJ; Millington DS; Bali DS
    Mol Genet Metab Rep; 2014; 1():461-464. PubMed ID: 27896123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
    Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
    Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples.
    Parkinson-Lawrence EJ; Muller VJ; Hopwood JJ; Brooks DA
    Clin Chim Acta; 2007 Feb; 377(1-2):88-91. PubMed ID: 17027703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome.
    Martell LA; Cunico RL; Ohh J; Fulkerson W; Furneaux R; Foehr ED
    Bioanalysis; 2011 Aug; 3(16):1855-66. PubMed ID: 21877895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity.
    Shams S; Barazandeh Tehrani M; Civallero G; Minookherad K; Giugliani R; Setoodeh A; Haghi Ashtiani MT
    J Diabetes Metab Disord; 2017; 16():37. PubMed ID: 28904929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA).
    Cole DE; Fukuda S; Gordon BA; Rip JW; LeCouteur AN; Rupar CA; Tomatsu S; Ogawa T; Sukegawa K; Orii T
    Am J Med Genet; 1996 Jun; 63(4):558-65. PubMed ID: 8826435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.
    Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N
    Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
    Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy in a murine model of Morquio A syndrome.
    Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
    Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
    Kim SM; Noh ES; Park JH; Park HD; Lee SY; Jang JH; Cho SY
    Ann Hum Genet; 2022 Nov; 86(6):361-368. PubMed ID: 36000290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
    Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
    PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Proteomic Analysis in Morquio A Disease.
    Álvarez JV; Bravo SB; Chantada-Vázquez MP; Barbosa-Gouveia S; Colón C; López-Suarez O; Tomatsu S; Otero-Espinar FJ; Couce ML
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).
    Tomatsu S; Montaño AM; Nishioka T; Gutierrez MA; Peña OM; Tranda Firescu GG; Lopez P; Yamaguchi S; Noguchi A; Orii T
    Hum Mutat; 2005 Dec; 26(6):500-12. PubMed ID: 16287098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA.
    Lawrence R; Prill H; Vachali PP; Adintori EG; de Hart G; Wang RY; Burton BK; Pasquali M; Crawford BE
    Glycobiology; 2020 Jul; 30(7):433-445. PubMed ID: 31897472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.